These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3457267)

  • 1. Gene therapy. Desperate appliances.
    Robertson M
    Nature; 1986 Mar 20-26; 320(6059):213-4. PubMed ID: 3457267
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy: current status and future directions.
    Cline J
    Schweiz Med Wochenschr; 1986 Oct; 116(43):1459-64. PubMed ID: 3538377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy of somatic cells: status and prospects.
    Orkin SH; Williams DA
    Prog Med Genet; 1988; 7():130-42. PubMed ID: 3277251
    [No Abstract]   [Full Text] [Related]  

  • 4. Retrovirus-mediated transfer and expression of drug resistance genes in human haematopoietic progenitor cells.
    Hock RA; Miller AD
    Nature; 1986 Mar 20-26; 320(6059):275-7. PubMed ID: 3960109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic gene therapy. Current status and future prospects.
    Williams DA; Orkin SH
    J Clin Invest; 1986 Apr; 77(4):1053-6. PubMed ID: 3514670
    [No Abstract]   [Full Text] [Related]  

  • 6. The hematopoietic stromal microenvironment promotes retrovirus-mediated gene transfer into hematopoietic stem cells.
    Chertkov JL; Jiang S; Lutton JD; Harrison J; Levere RD; Tiefenthaler M; Abraham NG
    Stem Cells; 1993 May; 11(3):218-27. PubMed ID: 8318909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo.
    Moritz T; Mackay W; Glassner BJ; Williams DA; Samson L
    Cancer Res; 1995 Jun; 55(12):2608-14. PubMed ID: 7780976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I.
    Pan D; Aronovich E; McIvor RS; Whitley CB
    Gene Ther; 2000 Nov; 7(21):1875-83. PubMed ID: 11110421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects for gene replacement therapy.
    Chang SM; Caskey CT
    Birth Defects Orig Artic Ser; 1987; 23(3):297-321. PubMed ID: 3307937
    [No Abstract]   [Full Text] [Related]  

  • 10. Umbilical cord blood stem cells as targets for genetic modification: new therapeutic approaches to somatic gene therapy.
    Williams DA; Moritz T
    Blood Cells; 1994; 20(2-3):504-15; discussion 515-6. PubMed ID: 7749118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase.
    Nivens MC; Felder T; Galloway AH; Pena MM; Pouliot JJ; Spencer HT
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):107-15. PubMed ID: 14605862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Umbilical cord blood cell transduction by retroviral vectors: preclinical studies to optimize gene transfer.
    Hanley ME; Nolta JA; Parkman R; Kohn DB
    Blood Cells; 1994; 20(2-3):539-43; discussion 544-6. PubMed ID: 7538356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulation of immune system via immortal bone marrow stem cells.
    Ruedl C; Khameneh HJ; Karjalainen K
    Int Immunol; 2008 Sep; 20(9):1211-8. PubMed ID: 18644831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of human bone morphogenetic protein 7 mRNA after the gene transfection in rabbit bone marrow-derived mesenchymal stem cells].
    Jin D; Zeng WS; Pei GX; Qi FJ; Wei KH; Wang K; Chen B
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):222-5. PubMed ID: 12390769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy utilizing drug resistance genes: a review.
    Banerjee D; Zhao SC; Li MX; Schweitzer BI; Mineishi S; Bertino JR
    Stem Cells; 1994 Jul; 12(4):378-85. PubMed ID: 7951004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cells expanded by fibroblast growth factor-1 are excellent targets for retrovirus-mediated gene delivery.
    Crcareva A; Saito T; Kunisato A; Kumano K; Suzuki T; Sakata-Yanagimoto M; Kawazu M; Stojanovic A; Kurokawa M; Ogawa S; Hirai H; Chiba S
    Exp Hematol; 2005 Dec; 33(12):1459-69. PubMed ID: 16338488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically marking human cells--results of the first clinical gene transfer studies.
    Cai Q; Rubin JT; Lotze MT
    Cancer Gene Ther; 1995 Jun; 2(2):125-36. PubMed ID: 7621260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34+-enriched peripheral blood progenitor cells.
    Takebe N; Zhao SC; Ural AU; Johnson MR; Banerjee D; Diasio RB; Bertino JR
    Cancer Gene Ther; 2001 Dec; 8(12):966-73. PubMed ID: 11781659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
    Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR-1 retroviral vector in a mouse gene therapy model.
    Hanania EG; Deisseroth AB
    Cancer Gene Ther; 1994 Mar; 1(1):21-5. PubMed ID: 7621234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.